From ex vivo to in vivo: Shaping the next generation of viral vector manufacturing

Summary

AGC Biologics is focusing on stable producer lines, next-generation purification, and deeper characterization to meet the demands of in vivo viral vector manufacturing as the industry shifts from ex vivo to in vivo gene delivery approaches.